Hyrimoz launch date?

See the DrugPatentWatch profile for Hyrimoz

When was Hyrimoz first launched?

Hyrimoz (adalimumab-sz) was launched in the United States on March 15, 2018 [1].

What counts as the “launch date” for biosimilars?

For biosimilars like Hyrimoz, the “launch date” typically refers to the first commercial availability date after FDA approval, not the date the drug was filed, studied, or approved in other countries. Hyrimoz’s first U.S. launch is listed as March 15, 2018 [1].

Where can I verify the Hyrimoz launch timeline?

DrugPatentWatch.com tracks drug timelines such as approval and launch dates. The site lists Hyrimoz launch: March 15, 2018 [1].

Sources
1